Metabolites as Prognostic Markers for Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Platinum-Doublet Chemotherapy

The metabolic requirements of metastatic non-small cell lung (mNSCLC) tumors from patients receiving first-line platinum-doublet chemotherapy are hypothesized to imprint a blood signature suitable for survival prediction. Pre-treatment samples prospectively collected at baseline from a randomized ph...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancers (Basel)
Hauptverfasser: Hao, Desirée, Sengupta, Arjun, Ding, Keyue, Ubeydullah, ER, Krishnaiah, Saikumari, Leighl, Natasha B., Shepherd, Frances A., Seymour, Lesley, Weljie, Aalim
Format: Artigo
Sprache:Inglês
Veröffentlicht: MDPI 2020
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7409233/
https://ncbi.nlm.nih.gov/pubmed/32708705
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12071926
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge